journal article·2015-05

Characterization of antimicrobial activity and mechanisms of low amphipathic peptides with different α-helical propensity

Xin Zhu, Licong Zhang, Jue Wang, Zhi Ma, Wei Xu, Jianping Li, Anshan Shan

Acta Biomaterialia· Volume 18
Publisher page

Abstract

Antimicrobial peptides (AMPs) serve as a defense mechanism within multicellular organisms and are attracting increasing attention because of their potential application in the treatment of multidrug-resistant infections. Amphipathicity has long been believed to be the most important consideration for the structural modification and design of both naturally occurring and synthetic AMPs. Previous studies indicated that disruptive amphipathicity formed by replacing the paired charged amino acid residues on the polar face of an amphipathic helix with tryptophan residues linked with hydrogen bonds on the basis of α-helical protein folding principles endowed the AMPs with increased cell selectivity. In an attempt to augment and hone this strategy further, we designed a series of imperfect amphipathic peptides by placing different types of amino acid residues at the hydrogen bond linked positions of α-helix structures to characterize their antimicrobial properties and mechanism of action. The d-Trp-substituted sequence (PRW4-d) showed greater antimicrobial potency than Cys-(C4), Asp-(D4), Ile-(I4), and Pro-(P4) substituted sequences, comparable to the l-Trp-substituted parent sequence (PRW4). Furthermore, the total replacement of Lys residues with Arg residues along the peptide sequence (PRW4-R) exhibited enhanced antimicrobial activity and cell selectivity. In addition, no cytotoxicity was observed among these synthetic peptides. PRW4-d and PRW4-R maintained their activities in the presence of physiological salts and human serum. The fluorescence spectroscopy, flow cytometry, and electron microscopy observations indicated that the optimized sequences exhibited excellent antimicrobial potency by inducing cytoplasmic membrane potential loss, membrane permeabilization and disruption. Collectively, the results could be useful for designing short AMPs with great antimicrobial activity and cell selectivity.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Antimicrobial Peptides and Activities · Biochemical and Structural Characterization · Chemical Synthesis and Analysis

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (63)

Show source-provided references
1. Platforms for antibiotic discovery10.1038/nrd3975 ↗
2. Effect of stereochemistry, chain length and sequence pattern on antimicrobial properties of short synthetic β-sheet forming peptide amphiphiles10.1016/j.biomaterials.2013.10.053 ↗
3. Antimicrobial peptides of multicellular organisms10.1038/415389a ↗
4. Antimicrobial peptides: natural effectors of the innate immune system10.1007/s00281-007-0064-5 ↗
5. Structural determinants of host defense peptides for antimicrobial activity and target cell selectivity10.1016/j.biochi.2010.02.023 ↗
6. Host defense peptides and their antimicrobial-immunomodulatory duality10.1016/j.imbio.2010.07.003 ↗
7. Host defense peptides: an alternative as antiinfective and immunomodulatory therapeutics10.1002/bip.22076 ↗
8. Overview on the recent study of antimicrobial peptides: origins, functions, relative mechanisms and application10.1016/j.peptides.2012.07.001 ↗
9. Peptide-membrane interactions and mechanisms of membrane destruction by amphipathic alpha-helical antimicrobial peptides10.1016/j.bbamem.2006.02.021 ↗
10. Cationic antimicrobial peptides in clinical development, with special focus on thanatin and heliomicin10.1007/s10096-011-1430-8 ↗
11. Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals?
12. Rationally designed α-helical broad-spectrum antimicrobial peptides with idealized facial amphiphilicity10.1002/marc.201200534 ↗
13. Alpha-helical antimicrobial peptides-using a sequence template to guide structure-activity relationship studies10.1016/j.bbamem.2006.03.021 ↗
14. The structure of proteins; two hydrogen-bonded helical configurations of the polypeptide chain10.1073/pnas.37.4.205 ↗
15. Compound helical configurations of polypeptide chains: structure of proteins of the alpha-keratin type10.1038/171059a0 ↗
16. Charge distribution and imperfect amphipathicity affect pore formation by antimicrobial peptides10.1016/j.bbamem.2012.01.016 ↗
17. Origin of low mammalian cell toxicity in a class of highly active antimicrobial amphipathic helical peptides10.1074/jbc.M709154200 ↗
18. Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index10.1074/jbc.M413406200 ↗
19. Jiang · Chem Biol Drug Des · 2011 · 77 · 22510.1111/j.1747-0285.2011.01086.x ↗
20. Design of imperfectly amphipathic alpha-helical antimicrobial peptides with enhanced cell selectivity10.1016/j.actbio.2013.08.043 ↗
21. A helix propensity scale based on experimental studies of peptides and proteins10.1016/S0006-3495(98)77529-0 ↗
22. The role of the central l- or d-pro residue on structure and mode of action of a cell-selective alpha-helical IsCT-derived antimicrobial peptide10.1016/j.bbrc.2005.07.029 ↗
23. Strand length-dependent antimicrobial activity and membrane-active mechanism of arginine- and valine-rich beta-hairpin-like antimicrobial peptides10.1128/AAC.06327-11 ↗
24. Membrane selectivity by W-tagging of antimicrobial peptides10.1016/j.bbamem.2010.12.020 ↗
25. Outer membrane differences between pathogenic and environmental Yersinia enterocolitica biogroups probed with hydrophobic permeants and polycationic peptides10.1128/iai.64.12.4891-4899.1996 ↗
26. Three-dimensional structure of membrane and surface proteins10.1146/annurev.bi.53.070184.003115 ↗
27. Antimicrobial peptides: primeval molecules or future drugs?10.1371/journal.ppat.1001067 ↗
28. Antimicrobial peptides with cell-penetrating peptide properties and vice versa10.1007/s00249-011-0682-7 ↗
29. Hemolytic and antimicrobial activities of the twenty-four individual omission analogs of melittin10.1021/bi00233a006 ↗
30. Proline-rich antimicrobial peptides: converging to a non-lytic mechanism of action10.1007/s00018-011-0721-7 ↗
31. A helix-PXXP-helix peptide with antibacterial activity without cytotoxicity against MDRPA-infected mice10.1016/j.biomaterials.2013.10.035 ↗
32. Effects of l- or d-pro incorporation into hydrophobic or hydrophilic helix face of amphipathic alpha-helical model peptide on structure and cell selectivity10.1016/j.bbrc.2003.12.142 ↗
33. Improved protease stability of the antimicrobial peptide Pin2 substituted with d-amino acids10.1007/s10930-013-9505-2 ↗
34. Improved proteolytic stability of chicken cathelicidin-2 derived peptides by d-amino acid substitutions and cyclization10.1016/j.peptides.2011.02.017 ↗
35. Twists, knots, and rings in proteins. Structural definition of the cyclotide framework10.1074/jbc.M211147200 ↗
36. Novel synthetic, salt-resistant analogs of human beta-defensins 1 and 3 endowed with enhanced antimicrobial activity10.1128/AAC.01550-09 ↗
37. Antimicrobial specificity and mechanism of action of disulfide-removed linear analogs of the plant-derived Cys-rich antimicrobial peptide Ib-AMP110.1016/j.peptides.2009.09.020 ↗
38. The effect of acidic residues and amphipathicity on the lytic activities of mastoparan peptides studied by fluorescence and CD spectroscopy10.1007/s00726-010-0511-9 ↗
39. Helix stabilization by Glu-…Lys+ salt bridges in short peptides of de novo design10.1073/pnas.84.24.8898 ↗
40. Effect of selectively introducing arginine and d-amino acids on the antimicrobial activity and salt sensitivity in analogs of human beta-defensins10.1371/journal.pone.0077031 ↗
41. Short synthetic β-sheet forming peptide amphiphiles as broad spectrum antimicrobials with antibiofilm and endotoxin neutralizing capabilities10.1002/adfm.201202850 ↗
42. Rationally designed alpha-helical broad-spectrum antimicrobial peptides with idealized facial amphiphilicity10.1002/marc.201200534 ↗
43. Membrane active antimicrobial activity and molecular dynamics study of a novel cationic antimicrobial peptide polybia-MPI, from the venom of polybia paulista10.1016/j.peptides.2012.11.002 ↗
44. Selective arginines are important for the antibacterial activity and host cell interaction of human alpha-defensin 510.1016/j.febslet.2009.06.051 ↗
45. Arginine-rich self-assembling peptides as potent antibacterial gels10.1016/j.biomaterials.2012.08.046 ↗
46. Synthetic mimic of antimicrobial peptide with nonmembrane-disrupting antibacterial properties10.1021/bm800855t ↗
47. Synthesis of short cationic antimicrobial peptidomimetics containing arginine analogues10.1002/psc.2435 ↗
48. Design and characterization of novel antimicrobial peptides, R-BP100 and RW-BP100, with activity against gram-negative and gram-positive bacteria10.1016/j.bbamem.2012.12.002 ↗
49. Cation-pi interactions in aromatics of biological and medicinal interest: electrostatic potential surfaces as a useful qualitative guide10.1073/pnas.93.20.10566 ↗
50. Cation-pi interactions in structural biology10.1073/pnas.96.17.9459 ↗
51. Optimization of the antimicrobial activity of magainin peptides by modification of charge10.1016/S0014-5793(01)02648-5 ↗
52. Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes10.1021/bi9619987 ↗
53. Designed low amphipathic peptides with α-helical propensity exhibiting antimicrobial activity via a lipid domain formation mechanism10.1016/j.peptides.2010.01.006 ↗
54. Mechanisms of antimicrobial peptide action and resistance10.1124/pr.55.1.2 ↗
55. Effects of cations and pH on antimicrobial activity of thanatin and s-thanatin against Escherichia coli ATCC25922 and B. subtilis ATCC 2133210.1007/s00284-008-9241-6 ↗
56. Inhibition of verocytotoxigenic Escherichia coli by antimicrobial peptides caseicin A and B and the factors affecting their antimicrobial activities10.1016/j.ijfoodmicro.2011.10.001 ↗
57. Effects of cations on antimicrobial activity of ostricacins-1 and 2 on E. coli O157:H7 and S. aureus 1056MRSA10.1007/s00284-006-0554-z ↗
58. Activity of the de novo engineered antimicrobial peptide WLBU2 against Pseudomonas aeruginosa in human serum and whole blood: implications for systemic applications10.1128/AAC.49.8.3208-3216.2005 ↗
59. The human antibacterial cathelicidin, hCAP-18, is bound to lipoproteins in plasma10.1074/jbc.274.32.22445 ↗
60. Outer membrane permeability and antibiotic resistance10.1016/j.bbapap.2008.11.005 ↗
61. Role of lipids in the interaction of antimicrobial peptides with membranes10.1016/j.plipres.2011.12.005 ↗
62. Depolarization, bacterial membrane composition, and the antimicrobial action of ceragenins10.1128/AAC.00380-10 ↗
63. Interactions of bacterial cationic peptide antibiotics with outer and cytoplasmic membranes of Pseudomonas aeruginosa10.1128/AAC.44.12.3317-3321.2000 ↗